respiratory diseases

Showing 2 posts of 2 posts found.

Chiesi expands La Chaussée-Saint-Victor site to manufacture next-gen inhalers

November 10, 2025
Manufacturing and Production Chiesi, Metered Dose Inhalers, Site Expansion, respiratory diseases

Chiesi, a biopharma group focused on treating respiratory diseases, has inaugurated an expansion of its manufacturing and industrial site in …

Osivax publishes positive results from trial of influenza vaccine candidate

July 15, 2025
Research and Development Osivax, Vaccine, Virology, clinical trial, influenza, respiratory diseases

French biopharma, Osivax, has announced positive results from its phase 2 study, OVX836-004, into OVX836, its broad-spectrum influenza vaccine lead …

The Gateway to Local Adoption Series

Latest content